Why the study?
Does His-Purkinje conduction system pacing combined with atrioventricular node ablation improve symptoms and quality of life in patients with persistent atrial fibrillation refractory to multiple ablation procedures?
Does His-Purkinje conduction system pacing combined with atrioventricular node ablation improve symptoms and quality of life in patients with persistent atrial fibrillation refractory to multiple ablation procedures?
His-Purkinje conduction system pacing combined with atrioventricular node ablation may be an effective strategy to improve symptoms and quality of life in patients with refractory persistent atrial fibrillation.
Answers are grounded in this paper and cite their sources.
May improve symptoms and QoL in refractory persistent AF; leaves open efficacy confirmation in prospective trials.
In patients with symptomatic atrial fibrillation refractory to optimal medical therapy, atrioventricular node ablation followed by permanent pacemaker implantation is an effective treatment option. A 66-year-old woman with symptomatic persistent atrial fibrillation refractory to multiple ablation procedures was referred to our institution. After optimal drug therapy, the patient still had obvious symptoms. Sequential His-Purkinje conduction system pacing and atrioventricular node ablation were performed. Left bundle branch pacing was used as a backup pacing method if thresholds of His bundle pacing were too high or loss of His bundle capture occurred in the follow-up. At the 6-month follow-up, the European Heart Rhythm Association classification for AF was improved, the score of the Atrial Fibrillation Effect on Quality of Life was enhanced, and the 6-Minute Walk Test was ameliorated. The present case was subjected to His-Purkinje conduction system pacing in combination with atrioventricular node ablation as treatment for a symptomatic persistent atrial fibrillation refractory to multiple ablation procedures, and this procedure alleviated symptoms and improved the quality of life in a short-term follow-up.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: